vs
Side-by-side financial comparison of CPI AEROSTRUCTURES INC (CVU) and Spero Therapeutics, Inc. (SPRO). Click either name above to swap in a different company.
CPI AEROSTRUCTURES INC is the larger business by last-quarter revenue ($19.4M vs $12.6M, roughly 1.5× Spero Therapeutics, Inc.). Spero Therapeutics, Inc. runs the higher net margin — 250.7% vs 3.6%, a 247.1% gap on every dollar of revenue. On growth, Spero Therapeutics, Inc. posted the faster year-over-year revenue change (24080.8% vs -10.8%). Over the past eight quarters, Spero Therapeutics, Inc.'s revenue compounded faster (847.7% CAGR vs 0.9%).
CPI Aerostructures Inc., known as CPI Aero, is a contract aircraft component manufacturer based in Edgewood, New York.
CVU vs SPRO — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $19.4M | $12.6M |
| Net Profit | $691.8K | $31.5M |
| Gross Margin | 20.3% | — |
| Operating Margin | 6.4% | — |
| Net Margin | 3.6% | 250.7% |
| Revenue YoY | -10.8% | 24080.8% |
| Net Profit YoY | -28.8% | 250.9% |
| EPS (diluted) | $0.04 | $0.56 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $19.4M | $12.6M | ||
| Q3 25 | $19.3M | $0 | ||
| Q2 25 | $15.2M | $0 | ||
| Q1 25 | $15.4M | $12.0K | ||
| Q4 24 | $21.8M | $52.0K | ||
| Q3 24 | $19.4M | $65.0K | ||
| Q2 24 | $20.8M | $114.0K | ||
| Q1 24 | $19.1M | $140.0K |
| Q4 25 | $691.8K | $31.5M | ||
| Q3 25 | $1.1M | $-7.4M | ||
| Q2 25 | $-1.3M | $-1.7M | ||
| Q1 25 | $-1.3M | $-13.9M | ||
| Q4 24 | $971.5K | — | ||
| Q3 24 | $749.7K | $-17.1M | ||
| Q2 24 | $1.4M | $-17.9M | ||
| Q1 24 | $168.2K | $-12.7M |
| Q4 25 | 20.3% | — | ||
| Q3 25 | 22.3% | — | ||
| Q2 25 | 4.4% | — | ||
| Q1 25 | 10.7% | — | ||
| Q4 24 | 20.0% | — | ||
| Q3 24 | 21.7% | — | ||
| Q2 24 | 24.6% | — | ||
| Q1 24 | 18.6% | — |
| Q4 25 | 6.4% | — | ||
| Q3 25 | 9.1% | — | ||
| Q2 25 | -13.1% | — | ||
| Q1 25 | -7.7% | -122758.3% | ||
| Q4 24 | 9.5% | — | ||
| Q3 24 | 7.6% | -28604.6% | ||
| Q2 24 | 11.2% | -16720.2% | ||
| Q1 24 | 4.4% | -9987.1% |
| Q4 25 | 3.6% | 250.7% | ||
| Q3 25 | 5.8% | — | ||
| Q2 25 | -8.7% | — | ||
| Q1 25 | -8.6% | -115550.0% | ||
| Q4 24 | 4.5% | — | ||
| Q3 24 | 3.9% | -26380.0% | ||
| Q2 24 | 6.8% | -15668.4% | ||
| Q1 24 | 0.9% | -9049.3% |
| Q4 25 | $0.04 | $0.56 | ||
| Q3 25 | $0.09 | $-0.13 | ||
| Q2 25 | $-0.10 | $-0.03 | ||
| Q1 25 | $-0.10 | $-0.25 | ||
| Q4 24 | $0.08 | — | ||
| Q3 24 | $0.06 | $-0.32 | ||
| Q2 24 | $0.11 | $-0.33 | ||
| Q1 24 | $0.01 | $-0.24 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $40.3M |
| Total DebtLower is stronger | $0 | — |
| Stockholders' EquityBook value | $25.8M | $59.0M |
| Total Assets | $75.2M | $68.9M |
| Debt / EquityLower = less leverage | 0.00× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $40.3M | ||
| Q3 25 | — | $48.6M | ||
| Q2 25 | — | $31.2M | ||
| Q1 25 | — | $48.9M | ||
| Q4 24 | — | $52.9M | ||
| Q3 24 | — | $76.3M | ||
| Q2 24 | — | $63.5M | ||
| Q1 24 | — | $82.3M |
| Q4 25 | $0 | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $26.5K | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $25.8M | $59.0M | ||
| Q3 25 | $25.0M | $26.5M | ||
| Q2 25 | $23.8M | $32.8M | ||
| Q1 25 | $24.9M | $33.8M | ||
| Q4 24 | $25.9M | $46.1M | ||
| Q3 24 | $24.9M | $65.5M | ||
| Q2 24 | $24.1M | $80.5M | ||
| Q1 24 | $22.5M | $96.2M |
| Q4 25 | $75.2M | $68.9M | ||
| Q3 25 | $74.1M | $54.2M | ||
| Q2 25 | $72.3M | $62.1M | ||
| Q1 25 | $65.4M | $77.7M | ||
| Q4 24 | $68.0M | $110.5M | ||
| Q3 24 | $68.9M | $135.2M | ||
| Q2 24 | $70.2M | $149.9M | ||
| Q1 24 | $70.8M | $167.7M |
| Q4 25 | 0.00× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.00× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-2.1M | $-8.4M |
| Free Cash FlowOCF − Capex | $-2.1M | — |
| FCF MarginFCF / Revenue | -10.8% | — |
| Capex IntensityCapex / Revenue | 0.0% | — |
| Cash ConversionOCF / Net Profit | -3.03× | -0.26× |
| TTM Free Cash FlowTrailing 4 quarters | $-5.3M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-2.1M | $-8.4M | ||
| Q3 25 | $212.1K | $17.4M | ||
| Q2 25 | $-596.3K | $-17.7M | ||
| Q1 25 | $-2.7M | $-4.0M | ||
| Q4 24 | $4.4M | $-23.4M | ||
| Q3 24 | $715.1K | $12.8M | ||
| Q2 24 | $-591.7K | $-18.7M | ||
| Q1 24 | $-960.5K | $5.9M |
| Q4 25 | $-2.1M | — | ||
| Q3 25 | $211.1K | — | ||
| Q2 25 | $-599.8K | — | ||
| Q1 25 | $-2.8M | — | ||
| Q4 24 | $4.3M | — | ||
| Q3 24 | $586.9K | — | ||
| Q2 24 | $-746.9K | — | ||
| Q1 24 | $-1.0M | — |
| Q4 25 | -10.8% | — | ||
| Q3 25 | 1.1% | — | ||
| Q2 25 | -4.0% | — | ||
| Q1 25 | -18.1% | — | ||
| Q4 24 | 19.9% | — | ||
| Q3 24 | 3.0% | — | ||
| Q2 24 | -3.6% | — | ||
| Q1 24 | -5.3% | — |
| Q4 25 | 0.0% | — | ||
| Q3 25 | 0.0% | — | ||
| Q2 25 | 0.0% | — | ||
| Q1 25 | 0.4% | — | ||
| Q4 24 | 0.3% | — | ||
| Q3 24 | 0.7% | — | ||
| Q2 24 | 0.7% | — | ||
| Q1 24 | 0.2% | — |
| Q4 25 | -3.03× | -0.26× | ||
| Q3 25 | 0.19× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 4.53× | — | ||
| Q3 24 | 0.95× | — | ||
| Q2 24 | -0.42× | — | ||
| Q1 24 | -5.71× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CVU
| Government Subcontracts | $16.4M | 85% |
| Commercial Contracts | $2.3M | 12% |
| Prime Government Contracts | $725.8K | 4% |
SPRO
Segment breakdown not available.
